These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Development and validation of models for predicting the response to intensive induction chemotherapy in acute non-lymphoblastic leukemia]. Sanz MA; Lorenzo JI Sangre (Barc); 1987; 32(5):463-9. PubMed ID: 3424049 [No Abstract] [Full Text] [Related]
3. [FAB classification, response to therapy, and survival in adult patients with acute leukemia (report II)]. Moriyama Y; Sato K; Narita M; Takeshige T; Saito H; Aoki S; Nakamori Y; Nagai K; Takizawa S; Soga N Rinsho Ketsueki; 1984 Oct; 25(10):1587-93. PubMed ID: 6520936 [No Abstract] [Full Text] [Related]
4. [Treatment of relapsing acute leukemia]. Yamada K; Kato Y Gan No Rinsho; 1983 Aug; 29(10):1092-5. PubMed ID: 6632196 [TBL] [Abstract][Full Text] [Related]
5. [Importance of changes in potassium in the management of patients with acute non-lymphoblastic leukemia]. Marazuela M; Díaz-Mediavilla J; Martínez R; del Potro E; Alvarez A; Espinós D Med Clin (Barc); 1986 Dec; 87(20):843-6. PubMed ID: 3807453 [No Abstract] [Full Text] [Related]
6. [Remission induction failures in adult acute non-lymphocytic leukemia]. Yoshida M; Furukawa Y; Akashi M; Komatsu N; Takeda K; Muroi K; Ikeda K; Ohsaka A; Ohta M; Takagi S Rinsho Ketsueki; 1985 Jun; 26(6):924-8. PubMed ID: 4068253 [No Abstract] [Full Text] [Related]
7. [Possibility of curing acute leukemias in adults: report of 22 cases of discontinued chemotherapy. When hope can become reality]. Sánchez Fayos J; Outeiriño J; De Villalobos E; Paniagua MC; Lite M; Figuera A; Pérez-Rus G; Calabuig MT; Serrano J Sangre (Barc); 1983; 28(5):617-27. PubMed ID: 6582652 [No Abstract] [Full Text] [Related]
8. [Prognostic factors related to remission duration and the effects of maintenance therapy in BHAC-DMP therapy in adult acute non-lymphocytic leukemia patients]. Morishima Y; Naoe T; Yokomaku S; Ohno R; Yamada K Rinsho Ketsueki; 1986 Aug; 27(8):1454-9. PubMed ID: 3795517 [No Abstract] [Full Text] [Related]
10. [Failures of remission induction in adult acute leukemia]. Honda T; Sampi K; Kumai R; Hattori M Rinsho Ketsueki; 1984 Jul; 25(7):1060-4. PubMed ID: 6502956 [No Abstract] [Full Text] [Related]
11. Methotrexate followed by L-asparaginase for the treatment of acute non lymphoid leukemia. Tribalto M; Amadori S; Avvisati G; Del Bianco P; Franchi A; Gallerano T; Papa G; Mandelli F Haematologica; 1985; 70(4):319-23. PubMed ID: 3935530 [No Abstract] [Full Text] [Related]
12. [Results using current therapy programs with acute leukemias in adults]. Perilov AA; Volkova MA; Frenkel' MA Vestn Akad Med Nauk SSSR; 1986; (5):18-23. PubMed ID: 3460275 [No Abstract] [Full Text] [Related]
13. [High-dose cytosine arabinoside and L-asparaginase in the treatment of refractory or recurrent acute non-lymphoblastic leukemia]. Sanz MA; Borrego D; Martín-Aragonés G; Martínez JA; Lorenzo I; Sanz G; Sayas MJ; Jarque I; Pastor E; Rafecas J Sangre (Barc); 1987; 32(4):476-81. PubMed ID: 3660187 [No Abstract] [Full Text] [Related]
14. Amsacrine with high-dose cytarabine in acute leukemia. Zittoun R; Bury J; Stryckmans P; Lowenberg B; Peetermans M; Rozendaal KY; Haanen C; Kerkhofs M; Jehn U; Willemze R Cancer Treat Rep; 1985 Dec; 69(12):1447-8. PubMed ID: 3841026 [No Abstract] [Full Text] [Related]
19. High rate of long-term survival in adult acute leukemia following ten-day chemotherapy (OAP) induction. Maintenance with chemotherapy or chemotherapy plus BCG vaccine. Hewlett JS; Chen T; Balcerzak SP; Gutterman JU; Costanzi JJ; Amare M Arch Intern Med; 1985 Jun; 145(6):1006-12. PubMed ID: 3890786 [TBL] [Abstract][Full Text] [Related]
20. Prediction of the response to chemotherapies in the patients with acute leukemias based on the initial cytogenetic analysis. Takeuchi J; Murakami J; Hayakawa Y Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1809-19. PubMed ID: 3836547 [No Abstract] [Full Text] [Related] [Next] [New Search]